Same Indication

Pembrolizumab vs Rivaroxaban

Pembrolizumab vs Rivaroxaban: Overview

This comparison examines the pharmacological differences between Pembrolizumab and Rivaroxaban.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Rivaroxaban: Direct Factor Xa inhibitor.

Pharmacokinetics

Half-life: Pembrolizumab — 26 days; Rivaroxaban — 5-9 hours.

Chemical Properties

Molecular Formula: Rivaroxaban — C19H18ClN3O5S.

Molecular Weight: Rivaroxaban — 435.8820 g/mol.

Type: Pembrolizumab — Antibody; Rivaroxaban — Small molecule.